AAV-mediated gene supplementation therapy in achromatopsia type 2: preclinical data on therapeutic time window and long-term effects
R Mühlfriedel, N Tanimoto, C Schön… - Frontiers in …, 2017 - frontiersin.org
Achromatopsia type 2 (ACHM2) is a severe, inherited eye disease caused by mutations in
the CNGA3 gene encoding the α subunit of the cone photoreceptor cyclic nucleotide-gated …
the CNGA3 gene encoding the α subunit of the cone photoreceptor cyclic nucleotide-gated …
Native cone photoreceptor cyclic nucleotide‐gated channel is a heterotetrameric complex comprising both CNGA3 and CNGB3: a study using the cone‐dominant …
AV Matveev, AB Quiambao… - Journal of …, 2008 - Wiley Online Library
Cone vision mediated by photoreceptor cyclic nucleotide‐gated (CNG) channel activation is
essential for central and color vision and visual acuity. Mutations in genes encoding the …
essential for central and color vision and visual acuity. Mutations in genes encoding the …
Gene therapy in color vision deficiency: a review
Z El Moussawi, M Boueiri, C Al-Haddad - International Ophthalmology, 2021 - Springer
Background Color vision deficiencies are a group of vision disorders, characterized by
abnormal color discrimination. They include red-green color blindness, yellow-blue color …
abnormal color discrimination. They include red-green color blindness, yellow-blue color …
Genetic basis of total colourblindness among the Pingelapese islanders
OH Sundin, JM Yang, Y Li, D Zhu, JN Hurd… - Nature …, 2000 - nature.com
Complete achromatopsia is a rare, autosomal recessive disorder characterized by
photophobia, low visual acuity, nystagmus and a total inability to distinguish colours. In this …
photophobia, low visual acuity, nystagmus and a total inability to distinguish colours. In this …
Molecular genetics of colour vision deficiencies
SS Deeb - Clinical and Experimental Optometry, 2004 - Wiley Online Library
Common variation in colour vision exists among both colour normal and colour deficient
subjects. Differences at a few amino acid positions that influence the spectra of the L and M …
subjects. Differences at a few amino acid positions that influence the spectra of the L and M …
Safety and biodistribution evaluation in CNGB3-deficient mice of rAAV2tYF-PR1. 7-hCNGB3, a recombinant AAV vector for treatment of achromatopsia
G Ye, E Budzynski, P Sonnentag, TM Nork… - Human Gene …, 2016 - liebertpub.com
Applied Genetic Technologies Corporation (AGTC) is developing rAAV2tYF-PR1. 7-
hCNGB3, a recombinant adeno-associated virus (rAAV) vector expressing the human …
hCNGB3, a recombinant adeno-associated virus (rAAV) vector expressing the human …
The use of tinted contact lenses in the management of achromatopsia
MM Schornack, WL Brown, DW Siemsen - Optometry-Journal of the …, 2007 - Elsevier
BACKGROUND: Achromatopsia is a congenital, autosomal recessively inherited condition
in which cones are either defective or absent. Complete achromatopsia results from having …
in which cones are either defective or absent. Complete achromatopsia results from having …
Endoplasmic reticulum stress-associated cone photoreceptor degeneration in cyclic nucleotide-gated channel deficiency
Cyclic nucleotide-gated (CNG) channels play a pivotal role in phototransduction. Mutations
in the cone CNG channel subunits CNGA3 and CNGB3 account for> 70% of all known …
in the cone CNG channel subunits CNGA3 and CNGB3 account for> 70% of all known …
Adaptive optics retinal imaging in CNGA3-associated achromatopsia: retinal characterization, interocular symmetry, and intrafamilial variability
Purpose: To investigate retinal structure in subjects with CNGA3-associated achromatopsia
and evaluate disease symmetry and intrafamilial variability. Methods: Thirty-eight …
and evaluate disease symmetry and intrafamilial variability. Methods: Thirty-eight …
Retinal structure and function in achromatopsia: implications for gene therapy
V Sundaram, C Wilde, J Aboshiha, J Cowing, C Han… - Ophthalmology, 2014 - Elsevier
Purpose To characterize retinal structure and function in achromatopsia (ACHM) in
preparation for clinical trials of gene therapy. Design Cross-sectional study. Participants …
preparation for clinical trials of gene therapy. Design Cross-sectional study. Participants …